Use of recombinant activated factor VII for massive postpartum hemorrhage

Acta Obstetricia et Gynecologica Scandinavica

Volumn 86, Issue 10, 2007, Pages 1200-1206

  Hossain, Nazli ^a   Shamsi, Tahir ^b   Haider, Saeeda ^c   Soomro, Nargis ^c   Khan, Nusrat H ^c   Memon, Ghuffrana Umer ^c   Farzana, Tasneem ^b   Ansari, Saqib ^b   Triche, Elizabeth W ^a   Kuczynski, Edward ^a   Lockwood, Charles J ^a   Paidas, Michael J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Bismillah Taqee Institute of Health Sciences and Blood Disorders   (Pakistan)

^c DOW UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

Author keywords

Coagulopathy; Massive postpartum hemorrhage; Maternal mortality; Pakistan

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ABSENCE OF SIDE EFFECTS; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG COST; ERYTHROCYTE TRANSFUSION; FEMALE; FEMALE FERTILITY; HUMAN; HYSTERECTOMY; MATERNAL MORTALITY; PARTIAL THROMBOPLASTIN TIME; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADULT; COAGULANTS; COHORT STUDIES; ERYTHROCYTE TRANSFUSION; FACTOR VIIA; FEMALE; HUMANS; MATERNAL MORTALITY; POSTPARTUM HEMORRHAGE; PREGNANCY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34648818183     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340701619324     Document Type: Article

References (24)

1. McLintock C. Postpartum haemorrhage. Thromb Res. 2005;(115 Suppl 1):65-8.
2. Mazouni C, Gorincour G, Juhan V, Bretelle F. Placenta accreta: a review of current advances in prenatal diagnosis. Placenta. 2006 July;28(7):599-603.
3. Hedner U. Recombinant factor VIIa (Novoseven) as a hemostatic agent. Semin Hematol. 2001;38(4 Suppl 12):43-7.
4. Warren O, Mandal K, Hadjianastassiou V, Knowlton L, Panesar S, John K, et al. Recombinant activated factor VII in cardiac surgery: a systematic review. Ann Thorac Surg. 2007;83(2):707-14.
5. Roberts HR, Monroe DM, White GC. The use of recombinant factor VIIa in the treatment of bleeding disorders. Blood. 2004;104(13):3858-64.
6. Franchini M, Zaffanello M, Veneri D. Recombinant factor VIIa. An update on its clinical use. Thromb Haemost. 2005;93(6):1027-35.
7. Bouwmeester FW, Jonkhoff AR, Verheijen RH, van Geijn HP. Successful treatment of life-threatening postpartum hemorrhage with recombinant activated factor VII. Obstet Gynecol. 2003;101(6):1174-6.
8. Lim Y, Loo CC, Chia V, Fun W. Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy. Int J Gynaecol Obstet. 2004;87(2):178-9.
9. Moscardo F, Perez F, de la Rubia J, Balerdi B, Lorenzo JI, Senent ML, et al. Successful treatment of severe intraabdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. Br J Haematol. 2001;114(1):174-6.
10. Shamsi TS, Hossain N, Soomro N, Hasan JA, Noorani M, Kazi S, et al. Use of recombinant factor VIIa for massive postpartum haemhorrage: case series and review of literature. J Pak Med Assoc. 2005;55(11):512-5.
11. Segal S, Shemesh IY, Blumenthal R, Yoffe B, Laufer N, Ezra Y, et al. Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa). Arch Gynecol Obstet. 2003;268(4):266-7.
12. Ahonen J, Jokela R. Recombinant factor VIIa for life-threatening postpartum haemorrhage. Br J Anaesth. 2005;94(5):592-5.
13. Ronsmans C. Maternal mortality: who, when, where, and why. Lancet. 2006;368(9542):1189-200.
14. AbouZahr C, Wardlaw T, Stanton C, Hill K. Maternal mortality. World Health Stat Q. 1996;49(2):77-87.
15. Mousa H, Alfirevic Z. Treatment for primary postpartum haemorrhage. Cochrane Database Syst Rev. (1):CD003249;2007.
16. Sobieszczyk S, Breborowicz GH, Platicanov V, Tanchev S, Kessler CM. Recombinant factor VIIa in the management of postpartum bleeds: an audit of clinical use. Acta Obstet Gynecol Scand. 2006;85(10):1239-47.
17. Scarpelini S, Rizoli S. Recombinant factor VIIa and the surgical patient. Curr Opin Crit Care. 2006;12(4):351-6.
18. Vincent JL, Rossaint R, Riou B, Ozier Y, Zideman D, Spahn DR. Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding - a European perspective. Crit Care. 2006;10(4):R120.
19. Mousa HA, Walkinshaw S. Major postpartum haemorrhage. Curr Opin Obstet Gynecol. 2001;13(6):595-603.
20. Smith J, Mousa HA. Peripartum hysterectomy for primary postpartum haemorrhage: incidence and maternal morbidity. J Obstet Gynaecol. 2007;27(1):44-7.
21. Karalapillai D, Popham P. Recombinant factor VIIa in massive postpartum haemorrhage. Int J Obstet Anesth. 2007;16(1):29-34.
22. Abshire T, Kenet G. Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors. J Thromb Haemost. 2004;2(6):899-909.
23. Eikelboom JW, Bird R, Blythe D, Coyle L, Gan E, Harvey M, et al. Recombinant activated factor VII for the treatment of life-threatening haemorrhage. Blood Coagul Fibrinolysis. 2003;14(8):713-7.
24. Haynes J, Laffan M, Plaat F. Use of recombinant activated factor VII in massive obstetric haemorrhage. Int J Obstet Anesth. 2007;16(1):40-9.